Capsule Receives 510(k) Clearance for SmartLinx Vitals Plus

Qualcomm subsidiary Capsule Technologie has received FDA 510(k) clearance for its SmartLinx Vitals Plus, a patient monitoring system that integrates vital signs monitoring and clinical documentation into one scalable platform.

Part of Capsule's SmartLinx platform, Vitals Plus allows healthcare facilities to streamline user authentication, patient identification, vitals measurements and clinical documentation by integrating vital signs modules directly to the SmartLinx Neuron 2 mobile clinical computer.

Capsule is planning a limited launch of the system to key customers during the fourth quarter of 2015, with wider distribution beginning in 2016.

Qualcomm acquired Andover, Mass.-based Capsule in September, gaining access to more than 1,900 hospital customers in 38 countries. — Michael Cipriano